ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05140	Leishmaniasis	2/3	75/7206	0.000318524000102
ko05145	Toxoplasmosis	2/3	126/7206	0.000899624305329
ko05152	Tuberculosis	2/3	187/7206	0.00197536797292
ko05310	Asthma	1/3	17/7206	0.00706172965882
ko05332	Graft-versus-host disease	1/3	18/7206	0.00747608698409
ko05330	Allograft rejection	1/3	24/7206	0.00995981037716
ko00220	Arginine biosynthesis	1/3	24/7206	0.00995981037716
ko05320	Autoimmune thyroid disease	1/3	29/7206	0.0120264118577
ko04940	Type I diabetes mellitus	1/3	32/7206	0.0132649912381
ko05150	Staphylococcus aureus infection	1/3	36/7206	0.0149148195516
ko04672	Intestinal immune network for IgA production	1/3	37/7206	0.0153269890831
ko05416	Viral myocarditis	1/3	55/7206	0.0227263934839
ko05321	Inflammatory bowel disease (IBD)	1/3	56/7206	0.0231363810127
ko00330	Arginine and proline metabolism	1/3	61/7206	0.0251845987509
ko00600	Sphingolipid metabolism	1/3	63/7206	0.0260030835227
ko04640	Hematopoietic cell lineage	1/3	64/7206	0.0264121540465
ko04612	Antigen processing and presentation	1/3	77/7206	0.0317196523231
ko05133	Pertussis	1/3	87/7206	0.0357891917913
ko04146	Peroxisome	1/3	89/7206	0.036601728957
ko05323	Rheumatoid arthritis	1/3	89/7206	0.036601728957
ko05222	Small cell lung cancer	1/3	89/7206	0.036601728957
ko04658	Th1 and Th2 cell differentiation	1/3	96/7206	0.0394420140777
ko05132	Salmonella infection	1/3	98/7206	0.0402524975102
ko05146	Amoebiasis	1/3	99/7206	0.0406575682064
ko04659	Th17 cell differentiation	1/3	106/7206	0.0434898721995